22/11/2006 (Agence Europe) - A study funded by the Solvay group, which is notably a manufacturer of vaccines, has pointed out that a significant part of the population is still not covered by flu vaccinations. According to this study, only 35% of people regarded as being high risk, have been vaccinated against seasonal influenza. The press release quotes Doctor Albert Osterhaus, who criticised the low take up of anti-flu vaccines in Europe and who also pointed out that the increase in...